Home » Topics » BioWorld Science

BioWorld Science
RSS

Pivotal study of Nucala in hypereosinophilic syndrome meets primary endpoint

Nov. 14, 2019

Phase IIa study of THX-110 in obstructive sleep apnea meets primary endpoint

Nov. 14, 2019

Bacteriophage "cocktail" fights drinking sequelae, PSC

Nov. 14, 2019

Phase I/II study of DF-1001 in advanced HER2-expressing sold tumors begins dosing

Nov. 14, 2019

Sichuan Kelun-Biotech Biopharmaceutical identifies new arginase-1 inhibitors

Nov. 14, 2019

Shanghai Leadopharma Technology presents antiepileptic compounds

Nov. 14, 2019

Sumitomo Dainippon Pharma patents mGlu2 receptor negative allosteric modulators

Nov. 14, 2019

AlaMab Therapeutics discloses connexin-43 antibodies

Nov. 14, 2019

KINE-101, a novel synthetic peptide for rheumatoid arthritis

Nov. 14, 2019

Anti-LAG-3 monoclonal antibodies described by Pharmaexplorer, Shanghai Pharmaexplorer

Nov. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...